HIV/AIDS Drug Resistance

Overview | News and Viewpoints | HIV/AIDS Mutations | Research

Overview

Recommendations for Using Drug Resistance Assays (PDF) (January 10, 2011)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Diagnostic, Monitoring and Resistance Laboratory Tests for HIV (June 2010)
To read PDF, click here.
From New York State Department of Health AIDS Institute
HIV Drug Resistance Mutations by Drug Class (PDF) (February 20, 2009)
From Stanford University
Primary Drug Resistance and Strategies for First-Line HIV Treatment (September 22, 2008)
From TheBodyPRO.com
HIV Resistance: Frequency, Testing, Mechanisms (PDF) (November/December 2007)
In Topics in HIV Medicine, from International AIDS Society-USA
HIV Drug Resistance Notes: Resistance Levels Conferred by Key Mutations (December 2004)
A class-by-class chart of drug resistance associated with specific HIV gene mutations, adapted from the Stanford HIV Drug Resistance Database.
To read PDF, click here.
In Infectious Diseases in Corrections Report, from Brown Medical School
Use of HIV Resistance Testing in Antiretroviral Therapy Decision Making (December 2004)
A clinical overview by Ian Frank, M.D.
To read PDF, click here.
In Infectious Diseases in Corrections Report, from Brown Medical School
Genotypic Testing for HIV-1 Drug Resistance (April 2004)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite
Mechanisms of HIV Drug Resistance: A Primer (March 2004)
In PRN Notebook, from Physician's Resarch Network
Assays for Antiretroviral Resistance (June 2002)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite

VIEW ALL ARTICLES

News & Viewpoints

Redefining Expanded Access for Patients With Multidrug-Resistant HIV (March 21, 2013)
From TheBodyPRO.com
Recreational Use of HIV Drugs Leading to Pre-Treatment Resistance in South Africa (December 19, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Emergence of Drug Resistance to ARVs Has Potential to "Curb, and Even Reverse" Gains Against HIV (June 19, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Study Shows Prevalence of Drug-Resistant HIV Strains in Uganda Rising, Among Highest in Sub-Saharan Africa (May 23, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
"Urgent Action" Needed to Prevent Resistance to Antiretroviral Therapy (September 27, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
IRIN/PlusNews Reports on Rise of Drug-Resistant Strains of HIV in Africa (February 9, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Global Drug Distribution Programs One Factor in Hastening Drug Resistance, Report Says (June 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Canada: Fewer HIV Patients Becoming Drug-Resistant -- B.C. Study (January 26, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Study Raises Concerns About Drug-Resistant HIV (January 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
S. African Doctor Sees Drug-Resistant HIV (January 4, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	Scientists Crack HIV's Coating
	HIV Management Today: Cardiovascular Risk Management in HIV Care: Facing Reality
	Enough With the HIV Treatment Cascade Research, Let's Do Something About It Already: A Blog Entry by Lisa Fitzpatrick, M.D., M.P.H.
	HIV Eradication Moves One Small Step Closer as Stem Cell Transplant Findings Titillate
	New Danish Results Spark Interest for Future HIV Cure Research
	Liquid Injectable Silicone Effective, Safe for Treating HIV Patients With Facial Lipoatrophy: Study

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.